Resection, transplantation and local regional therapies for liver adenomas

References

• Baum JK, Bookstein JJ, Holtz F, Klein EW. Possible association between benign hepatomas and oral contraceptives. Lancet 1973;2(7835):926-9
   PubMedGoogle Scholar
• Rooks JB, Ory HW, Ishak KG, et al. Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979;242(7):644-8
   PubMed Web of Science ®Google Scholar
• Rosenberg L. The risk of liver neoplasia in relation to combined oral contraceptive use. Contraception 1991;43(6):643-52
   PubMedGoogle Scholar
• Toso C, Majno P, Andres A, et al. Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol 2005;11(36):5691-5
   PubMedGoogle Scholar
• Paradis V, Benzekri A, Dargère D, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004;126(5):1323-9
   PubMedGoogle Scholar
• Bioulac-Sage P, Rebouissou S, Thomas C, et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 2007;46(3):740-8
   PubMed Web of Science ®Google Scholar
• Laumonier H, Bioulac-Sage P, Laurent C, et al. Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 2008;48(3):808-18
   PubMed Web of Science ®Google Scholar
• Cho SW, Marsh JW, Steel J, et al. Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008;15(10):2795-803
   PubMed Web of Science ®Google Scholar
• Dokmak S, Paradis V, Vilgrain V, et al. A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas. Gastroenterology 2009;137(5):1698-705
   PubMed Web of Science ®Google Scholar
• Deneve JL, Pawlik TM, Cunningham S, et al. Liver cell adenoma: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 2009;16(3):640-8
   PubMed Web of Science ®Google Scholar
• Farges O, Ferreira N, Dokmak S, et al. Changing trends in malignant transformation of hepatocellular adenoma. Gut 2011;60(1):85-9
   PubMed Web of Science ®Google Scholar
• Ronot M, Bahrami S, Calderaro J, et al. Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 2011;53(4):1182-91
   PubMed Web of Science ®Google Scholar
• Mounajjed T, Wu TT. Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection. Am J Surg Pathol 2011;35(9):1356-63
   PubMedGoogle Scholar
• van Vledder MG, van Aalten SM, Terkivatan T, et al. Safety and efficacy of radiofrequency ablation for hepatocellular adenoma. J Vasc Interv Radiol 2011;22(6):787-93
   PubMed Web of Science ®Google Scholar
• Erdogan D, van Delden OM, Busch OR, et al. Selective transcatheter arterial embolization for treatment of bleeding complications or reduction of tumor mass of hepatocellular adenomas. Cardiovasc Intervent Radiol 2007;30(6):1252-8
   PubMedGoogle Scholar
• Deodhar A, Brody LA, Covey AM, et al. Bland embolization in the treatment of hepatic adenomas: preliminary experience. J Vasc Interv Radiol 2011;22(6):795-9
   PubMed Web of Science ®Google Scholar
• Rebouissou S, Amessou M, Couchy G, et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature 2009;457(7226):200-4
   PubMed Web of Science ®Google Scholar
• Nault JC, Bioulac-Sage P, Zucman-Rossi J. Hepatocellular benign tumors-from molecular classification to personalized clinical care. Gastroenterology 2013;144(5):888-902
   PubMed Web of Science ®Google Scholar
• Carrasco D, Barrachina M, Prieto M, Berenguer J. Clomiphene citrate and liver-cell adenoma. N Engl J Med 1984;310(17):1120-1
   PubMedGoogle Scholar
• Espat J, Chamberlain RS, Sklar C, Blumgart LH. Hepatic adenoma associated with recombinant human growth hormone therapy in a patient with Turner’s syndrome. Dig Surg 2000;17(6):640-3
   PubMedGoogle Scholar
• Bork K, Pitton M, Harten P, Koch P. Hepatocellular adenomas in patients taking danazol for hereditary angio-oedema. Lancet 1999;353(9158):1066-7
   PubMedGoogle Scholar
• Velazquez I, Alter BP. Androgens and liver tumors: Fanconi’s anemia and non-Fanconi’s conditions. Am J Hematol 2004;77(3):257-67
   PubMed Web of Science ®Google Scholar
• Nakao A, Sakagami K, Nakata Y, et al. Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 2000;35(7):557-62
   PubMed Web of Science ®Google Scholar
• Socas L, Zumbado M, Pérez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 2005;39(5):e27
   Web of Science ®Google Scholar
• Bunchorntavakul C, Bahirwani R, Drazek D, et al. Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 2011;34(6):664-74
   PubMedGoogle Scholar
• Bioulac-Sage P, Taouji S, Possenti L, Balabaud C. Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver Int 2012;32(8):1217-21
   PubMedGoogle Scholar
• Chang CY, Hernandez-Prera JC, Roayaie S, et al. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol 2013;2013:604860
   PubMedGoogle Scholar
• Brunt EM, Wolverson MK, Di Bisceglie AM. Benign hepatocellular tumors (adenomatosis) in nonalcoholic steatohepatitis: a case report. Semin Liver Dis 2005;25(2):230-6
   PubMedGoogle Scholar
• Smith BM, Hussain A, Jacobs M, Merrick HW 3rd. Ruptured hepatocellular carcinoma in a patient with nonalcoholic steatohepatitis. Surg Obes Relat Dis 2009;5(4):510-12
   PubMedGoogle Scholar
• Heinemann LA, Weimann A, Gerken G, et al. Modern oral contraceptive use and benign liver tumors: the German Benign Liver Tumor Case-Control Study. Eur J Contracept Reprod Health Care 1998;3(4):194-200
   PubMedGoogle Scholar
• Reddy SK, Kishnani PS, Sullivan JA, et al. Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 2007;47(5):658-63
   PubMedGoogle Scholar
• Wang DQ, Fiske LM, Carreras CT, Weinstein DA. Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr 2011;159(3):442-6
   PubMed Web of Science ®Google Scholar
• Calderaro J, Labrune P, Morcrette G, et al. Molecular characterization of hepatocellular adenomas developed in patients with glycogen storage disease type I. J Hepatol 2013;58(2):350-7
   PubMedGoogle Scholar
• Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384(6608):455-8
   PubMed Web of Science ®Google Scholar
• Bacq Y, Jacquemin E, Balabaud C, et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology 2003;125(5):1470-5
   PubMedGoogle Scholar
• Reznik Y, Dao T, Coutant R, et al. Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families. J Clin Endocrinol Metab 2004;89(3):1476-80
   PubMedGoogle Scholar
• Rebouissou S, Imbeaud S, Balabaud C, et al. HNF1alpha inactivation promotes lipogenesis in human hepatocellular adenoma independently of SREBP-1 and carbohydrate-response element-binding protein (ChREBP) activation. J Biol Chem 2007;282(19):14437-46
   PubMedGoogle Scholar
• Iwen KA, Klein J, Hubold C, et al. Maturity-onset diabetes of the young and hepatic adenomatosis - characterisation of a new mutation. Exp Clin Endocrinol Diabetes 2013;121(6):368-71
   PubMedGoogle Scholar
• Kawakatsu M, Vilgrain V, Belghiti J Flejou JF, Nahum H. Association of multiple liver cell adenomas with spontaneous intrahepatic portohepatic shunt. Abdom Imaging 1994;19(5):438-40
   PubMedGoogle Scholar
• Seyama Y, Sano K, Tang W, et al. Simultaneous resection of liver cell adenomas and an intrahepatic portosystemic venous shunt with elevation of serum PIVKA-II level. J Gastroenterol 2006;41(9):909-12
   PubMedGoogle Scholar
• Pupulim LF, Vullierme MP, Paradis V, et al. Congenital portosystemic shunts associated with liver tumours. Clin Radiol 2013;68(7):e362-9
   Google Scholar
• Maillette de Buy Wenniger L, Terpstra V, Beuers U. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 2010;27(1):24-31
   PubMedGoogle Scholar
• Witjes CD, Ten Kate FJ, van Aalten SM, et al. Hepatocellular adenoma as a risk factor for hepatocellular carcinoma in a non-cirrhotic liver: a plea against. Gut 2012;61(11):1645-6
   PubMedGoogle Scholar
• Singhi AD, Jain D, Kakar S, et al. Reticulin loss in benign fatty liver: an important diagnostic pitfall when considering a diagnosis of hepatocellular carcinoma. Am J Surg Pathol 2012;36(5):710-15
   PubMedGoogle Scholar
• Brancatelli G, Federle MP, Vullierme MP, et al. CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 2006;30(5):745-50
   PubMedGoogle Scholar
• Chung KY, Mayo-Smith WW, Saini S, et al. Hepatocellular adenoma: MR imaging features with pathologic correlation. AJR Am J Roentgenol 1995;165(2):303-8
   PubMedGoogle Scholar
• Bieze M, van den Esschert JW, Nio CY, et al. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 2012;199(1):26-34
   PubMed Web of Science ®Google Scholar
• Purysko AS, Remer EM, Coppa CP, et al. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 2012;198(1):115-23
   PubMedGoogle Scholar
• Grazioli L, Bondioni MP, Haradome H, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012;262(2):520-9
   PubMedGoogle Scholar
• Paradis V, Champault A, Ronot M, et al. Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007;46(1):140-6
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Kok NF, Hussain SM, et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006;93(12):1495-502
   PubMedGoogle Scholar
• van Aalten SM, de Man RA, IJzermans JN, Terkivatan T. Systematic review of haemorrhage and rupture of hepatocellular adenomas. Br J Surg 2012;99(7):911-16
   PubMed Web of Science ®Google Scholar
• Battula N, Tsapralis D, Takhar A, et al. Aetio-pathogenesis and the management of spontaneous liver bleeding in the West: a 16-year single-centre experience. HPB (Oxford 2012;14(6):382-9
   PubMed Web of Science ®Google Scholar
• Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208(5):558-64
   PubMedGoogle Scholar
• Marini P, Vilgrain V, Belghiti J. Management of spontaneous rupture of liver tumours. Dig Surg 2002;19(2):109-13
   PubMedGoogle Scholar
• Stoot JH, Coelen RJ, De Jong MC, Dejong CH. Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford) 2010;12(8):509-22
   PubMed Web of Science ®Google Scholar
• Farges O, Dokmak S. Malignant transformation of liver adenoma: an analysis of the literature. Dig Surg 2010;27(1):32-8
   PubMedGoogle Scholar
• Zucman-Rossi J, Jeannot E, Nhieu JT, et al. Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006;43(3):515-24
   PubMed Web of Science ®Google Scholar
• Chiche L, Dao T, Salamé E, et al. Liver adenomatosis: reappraisal, diagnosis, and surgical management: eight new cases and review of the literature. Ann Surg 2000;231(1):74-81
   PubMedGoogle Scholar
• Veteläinen R, Erdogan D, de Graaf W, et al. Liver adenomatosis: re-evaluation of aetiology and management. Liver Int 2008;28(4):499-508
   PubMedGoogle Scholar
• Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ. Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 1998;4(5):388-98
   PubMedGoogle Scholar
• Karkar AM, Tang LH, Kashikar ND, et al. Management of hepatocellular adenoma: comparison of resection, embolization and observation. HPB 2013;15(3):235-43
   PubMedGoogle Scholar
• van Aalten SM, Terkivatan T, de Man RA, et al. Diagnosis and treatment of hepatocellular adenoma in the Netherlands: similarities and differences. Dig Surg 2010;27(1):61-7
   PubMedGoogle Scholar
• Noels JE, van Aalten SM, van der Windt DJ, et al. Management of hepatocellular adenoma during pregnancy. J Hepatol 2011;54(3):553-8
   PubMedGoogle Scholar
• Bühler H, Pirovino M, Akobiantz A, et al. Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 1982;82(4):775-82
   PubMedGoogle Scholar
• Aseni P, Sansalone CV, Sammartino C, et al. Rapid disappearance of hepatic adenoma after contraceptive withdrawal. J Clin Gastroenterol 2001;33(3):234-6
   PubMedGoogle Scholar
• Svrcek M, Jeannot E, Arrivé L, et al. Regressive liver adenomatosis following androgenic progestin therapy withdrawal: a case report with a 10-year follow-up and a molecular analysis. Eur J Endocrinol 2007;156(6):617-21
   PubMedGoogle Scholar
• van Aalten SM, Witjes CD, de Man RA, et al. Can a decision-making model be justified in the management of hepatocellular adenoma? Liver Int 2012;32(1):28-37
   PubMedGoogle Scholar
• van der Windt DJ, Kok NF, Hussain SM, et al. Case-orientated approach to the management of hepatocellular adenoma. Br J Surg 2006;93(12):1495-502
   PubMedGoogle Scholar
• Bioulac-Sage P, Laumonier H, Couchy G, et al. Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 2009;50(2):481-9
   PubMedGoogle Scholar
• Huurman VA, Schaapherder AF. Management of ruptured hepatocellular adenoma. Dig Surg 2010;27(1):56-60
   PubMedGoogle Scholar
• Brenner DJ, Hall EJ. Computed tomography--an increasing source of radiation exposure. N Engl J Med 2007;357(27):2277-84
   PubMedGoogle Scholar
• Buell JF, Cherqui D, Geller DA, et al. World Consensus Conference on Laparoscopic Surgery. The international position on laparoscopic liver surgery: the Louisville Statement, 2008. Ann Surg 2009;250(5):825-30
   PubMed Web of Science ®Google Scholar
• Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg 2011;253(4):656-65
   PubMed Web of Science ®Google Scholar
• Dokmak S, Raut V, Aussilhou B, et al. Laparoscopic left lateral resection is the gold standard for benign liver lesions: a case-control study. HPB (Oxford) 2014;16(2):183-7
   PubMed Web of Science ®Google Scholar
• Reddy SK, Austin SL, Spencer-Manzon M, et al. Liver transplantation for glycogen storage disease type Ia. J Hepatol 2009;51(3):483-90
   PubMedGoogle Scholar
• Stoot JH, van der Linden E, Terpstra OT, Schaapherder AF. Life-saving therapy for haemorrhaging liver adenomas using selective arterial embolization. Br J Surg 2007;94(10):1249-53
   PubMedGoogle Scholar
• Kobayashi S, Sakaguchi H, Takatsuka M, et al. Two cases of hepatocellular adenomatosis treated with transcatheter arterial embolization. Hepatol Int 2009;3(2):416-20
   PubMedGoogle Scholar
• Erdogan D, Busch OR, van Delden OM, et al. Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 2006;26(4):433-8
   PubMedGoogle Scholar
• Terkivatan T, de Wilt JH, de Man RA, et al. Treatment of ruptured hepatocellular adenoma. Br J Surg 2001;88(2):207-9
   PubMedGoogle Scholar
• Atwell TD, Brandhagen DJ, Charboneau JW, et al. Successful treatment of hepatocellular adenoma with percutaneous radiofrequency ablation. AJR Am J Roentgenol 2005;184(3):828-31
   PubMedGoogle Scholar
• Rhim H, Lim HK, Kim YS, Choi D. Percutaneous radiofrequency ablation of hepatocellular adenoma: initial experience in 10 patients. J Gastroenterol Hepatol 2008;23(8 Pt 2):e422-7
   Google Scholar
• Fujita S, Kushihata F, Herrmann GE, et al. Combined hepatic resection and radiofrequency ablation for multiple hepatic adenomas. J Gastroenterol Hepatol 2006;21(8):1351-4
   PubMedGoogle Scholar
• Agrawal S, Daruwala C. Metabolic syndrome and hepatic resection: improving outcome. HPB (Oxford) 2011;13(12):846-59
   PubMedGoogle Scholar
• van der Sluis FJ, Bosch JL, Terkivatan T, et al. Hepatocellular adenoma: cost-effectiveness of different treatment strategies. Radiology 2009;252(3):737-46
   PubMedGoogle Scholar
• Jeng LB, Chen MF. Intrahepatic portohepatic venous shunt. A case report of successful surgical resection. Arch Surg 1993;128(3):349-52
   PubMedGoogle Scholar
• Tanoue S, Kiyosue H, Komatsu E, et al. Symptomatic intrahepatic portosystemic venous shunt: embolization with an alternative approach. AJR Am J Roentgenol 2003;181(1):71-8
   PubMedGoogle Scholar